Integra Lifesciences Holdings Corp (IART) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Integra Lifesciences Holdings Corp  (NASDAQ: IART)


Integra Lifesciences Holdings's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Integra Lifesciences Holdings's ROI in the second quarter of 2026?
Integra Lifesciences Holdings Corp recorded a cumulative net loss of $-7 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -0.22%.

Within the Healthcare sector 47 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3156 to 3167.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 10.07 % 0.12 % -3.54 % -5.39 % -11.03 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3,233 3,256 3,146 3,308 2,738
Return On Investment (TTM) -0.22 % -15.93 % -16.76 % -16.21 % -17.03 %
IART's Overall Ranking # 3167 # 3156 # 2495 # 2877 # 2606
Seq. Investment Change TTM 3.97 % 0.99 % 0.84 % 3.94 % -5.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -7 -496 -516 -495 -501

IART Company Profile >> Back to IART Roi Comparisons >> See Annual IART Return On Investment



Return On Investment IART's Ranking
Within: No.
Industry # 15
Sector # 48
Overall # 3167

Return On Investment Statistics
High Average Low
6.33 %
0.87 %
-16.15 %
(Sep 30 2021)   (Jun 30 2025)



  News about Integra Lifesciences Holdings Corp Return on Investment ROI

Integra LifeSciences Announces Plans for State-of-the-Art Manufacturing Facility in Braintree, Massachusetts, Boosting IART Shares by 5.66%

July 15, 2024

Integra LifeSciences Aims to Boost Production with New Cutting-Edge Facility in Braintree, Massachusetts, Fuelling Growth Prospects for Investors
Integra LifeSciences, a leading global medical technology company, is set to revolutionize its manufacturing capabilities with plans to operationalize a state-of-the-art facility in Braintree, Massachusetts by the first half of 2026. The company s decision to invest in this advanced facility comes as IART shares witnessed an impressive surge of 5.66%, signaling a promising future for investors.
Integra LifeSciences commitment to providing innovative medical solutions has been a driving force behind its success in the industry. The decision to establish a new manufacturing facility represents the company s vision for streamlining and expanding its production capabilities, ultimately aiming to meet the growing demand for its top-notch medical technologies.

Integra Lifesciences Announces Leadership Transition Plan amid Positive Financial Performance

February 28, 2024



Integra Lifesciences Holdings Corp, a leading medical technology company, has recently made significant leadership changes and achieved commendable financial results. These developments showcase Integra s commitment to innovation and growth in the healthcare sector. As the company prepares for a transition in its leadership team, investors and stakeholders eagerly anticipate the future trajectory of this influential organization.
Leadership Transition Plan:
Integra Lifesciences recently announced that Jan De Witte, the current CEO, will retire by the end of 2024. De Witte has been instrumental in driving Integra s success and growth during his tenure. His visionary leadership has positioned the company as a leading provider of advanced medical technologies. Stuart Essig, a seasoned executive, has been appointed as the executive chairman of the Board. Essig brings a wealth of experience and expertise to the role, making him an ideal candidate to oversee the transition and ensure continuity.





Financial Statements
Integra Lifesciences Holdings's II. Quarter Investments $ 3,233 Millions IART's Balance sheet
Integra Lifesciences Holdings's II. Quarter Income $ 4 Millions Quarterly IART's Income Statement
IART's Income by Division See IART's Income by Division


IART Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,977 2,779 3,184 3,243 3,442
Y / Y Investment Growth 7.12 % -12.7 % -1.84 % -5.78 % 7.1 %
Net Income in Millions -516 -7 68 181 169
Y / Y Net Income Growth - - -62.48 % 6.79 % 26.28 %
Annual Return On Investment -17.35 % -0.25 % 2.13 % 5.57 % 4.91 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IART's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IART's Competitors
Subscribers only: Roi for Integra Lifesciences Holdings's Suppliers
Subscribers only: Return On Investment for IART's Customers

Other Ratios
IART's Roa IART's Inventory Turnover Ratio IART's Growth Rates IART's Dividend Statistics
IART's Profitability Ratios IART's Asset Turnover Ratio IART's Dividend Growth
IART's Roe IART's Valuation Ratios IART's Financial Strength Ratios IART's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:16:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.